Statistics

Total Visits

Views
Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model (IMRCC), in patients (pt) treated with pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): First results of the SOGUG SPAZO study57

Select a period of time:

Number of views in the range

Views
Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model (IMRCC), in patients (pt) treated with pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): First results of the SOGUG SPAZO study14

Views

Views
November 20250
December 20250
January 20260
February 20260
March 20263
April 20260
May 202611
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States3
Turkey2
Mexico2
Chile1
Colombia1
Ecuador1
Spain1
Finland1
Portugal1
South Africa1
 

Top cities views

Views
Acapulco de Juárez1
Bucaramanga1
Buffalo1
Bursa1
Funchal1
Helsinki1
Istanbul1
Lichtenburg1
Quito1
Santiago1